PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for March 26, 2008 Subscribe to this News Feed    
 

TomoTherapy Issues Treatment Quality Challenge

MADISON, Wis. (Business Wire EON/PRWEB ) March 26, 2008 -- TomoTherapy Incorporated (NASDAQ:TOMO), maker of the TomoTherapy® Hi·Art® treatment system for advanced radiation therapy, announced today that it has issued a Treatment Quality Challenge. TomoTherapy will award $250,000 to any U.S. cancer center that demonstrates its ability to beat the quality of a TomoTherapySM treatment plan using the new RapidArc product from Varian Medical Systems.

We believe that, even as radiation therapy vendors work to improve clinical efficiency, the highest-quality patient treatments must remain our industrys primary focus, said Fred Robertson, CEO of TomoTherapy. With this challenge, we aim to provide a forum for U.S. clinicians to objectively review the quality that a continuous helical TomoTherapy treatment affords over a two-minute, single-rotation RapidArc delivery.

News Image Cancer centers are encouraged to learn more about this challenge, and to register, at TomoTherapy.com.

About TomoTherapy Incorporated

TomoTherapy Incorporated has developed, markets and sells the TomoTherapy® Hi·Art® treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi·Art treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The companys stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

©2008 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated. RapidArc is a trademark of Varian Medical Systems.

See the original story at: http://eon.businesswire.com/releases/tomotherapy/treatment/prweb804504.htm

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/VGhpci1Mb3ZlLUluc2UtU3F1YS1TdW1tLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION

TomoTherapy Incorporated
Investor Contact:
Stephen C. Hathaway
Chief Financial Officer
608.824.2800
shathaway@tomotherapy.com
or
Media Contact:
Patty Kitowski
Marketing Communications Manager
608.824.2820
pkitowski@tomotherapy.com

ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move